Clinical Trial of the efficacy and safety of topical phenothrin lotion and ivermectin lotion for head lice infestations.

Clinical Trial of the efficacy and safety of topical phenothrin lotion and ivermectin lotion for head lice infestations. - Clinical Trial of the efficacy and safety of topical phenothrin lotion and ivermectin lotion for head lice infestations.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016170

Enrollment

Registered

2015-01-09

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head lice infestations

Interventions

(1)Term

It is planned three months from July, 2015 (2)Study drug and the number of doses

Twice application of sumithrin lotion 5% . (1)Term

First application is sumithrin lotion 5% and second application is Sklice lotion 0.5%.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1)More than 6-month-old patient who was received a diagnosis of head lice infestations. (2)A patient who understood sufficiently and done voluntary documentary agreement by subject or legal representative after a sufficient explanation. But if a subject is more than 16 years old and less than 20 years old,we must get a nod from a subject after agreement of legal representative. (3)A patient who does not have other medical treatments to head lice infestations during this research participation. (4)A patient who does not cut and are not treated with a chemical like coloring and perm during this research participation.

Exclusion criteria

Exclusion criteria: (1)A patient who has obstacle of a barrier of skin by head skin diseases. (2)A patient who has the following disease. The disease which can have an effect on test outcome judged by a test doctor in attendance, or the disease which can have a bad effect by application of phenothrin or ivermectin. (3)A patient with the medical history which is sensitivity to the components of sumithrin lotion 5% or Sklice lotion 0.5%,other pediculicides,insecticides ,hair care goods. (4)A patient who received treatments for head lice infestations(OTC, home remedy, prescription)in the last 4 weeks. (5)A female who is pregnant, possibility of pregnancy,nursing. (6)Drugs and alcohol abuser. (7)Illegal drugs addict. (8)A patient who participated in a clinical trial in the last 4 weeks. (9)A patient who judged by a test doctor in attendance to be unsuitable as a subject.

Design outcomes

Primary

Measure	Time frame
The percentage of patients who were not observed of head louse(regardless of life or death) after application of test drugs(cure rate).	—

Countries

Japan

Contacts

Public ContactMasayo Komoda

Division of pharmacy,Faculty of Pharmaceutical Sciences, Tokyo university of science Department of medical safety

komo1207@rs.noda.tus.ac.jp04-7121-4134

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026